Kaynes Technology Board Approves Unaudited Financial Results for Q3 2026

Kaynes Technology India Limited has announced the approval of its unaudited financial results for the quarter and nine months ended December 31, 2025. The decision was made during a board meeting held on February 5, 2026. The standalone financial results show revenue from operations at ₹5,217.55 million for Q3 and ₹14,397.05 million for the nine-month period.

Q3 2026 Financial Highlights

Kaynes Technology India Limited’s Board of Directors has approved the unaudited standalone and consolidated financial results for Q3 (October-December) of FY26. The results showcase the company’s performance in key financial metrics.

Standalone Financial Performance

The standalone results reveal the following key figures:

  • Revenue from Operations:₹5,217.55 million for the quarter ended December 31, 2025, compared to ₹3,958.98 million for the quarter ended December 31, 2024.
  • Total Income:₹5,685.03 million for the quarter ended December 31, 2025.
  • Profit for the period:₹659.82 million for the quarter ended December 31, 2025.
  • Earnings per share (Basic):₹9.85 for the quarter.

Nine-Month Standalone Performance

  • Revenue from Operations:₹14,397.05 million for the nine months ended December 31, 2025, compared to ₹11,788.97 million for the nine months ended December 31, 2024.
  • Total Income:₹15,745.41 million for the nine months ended December 31, 2025.
  • Profit for the period:₹1,831.65 million for the nine months ended December 31, 2025.
  • Earnings per share (Basic):₹27.91 for the nine months.

Consolidated Financial Performance

The consolidated results include the financial performance of Kaynes Technology and its subsidiaries.

  • Revenue from operations:₹8,040.32 million for the quarter ended December 31, 2025, compared to ₹6,611.75 million for the quarter ended December 31, 2024.
  • Total Income:₹8,488.36 million for the quarter ended December 31, 2025.
  • Profit for the period:₹766.42 million for the quarter ended December 31, 2025.
  • Earnings per share (Basic):₹11.34 for the quarter.

Nine-Month Consolidated Performance

  • Revenue from operations:₹23,837.16 million for the nine months ended December 31, 2025, compared to ₹17,372.69 million for the nine months ended December 31, 2024.
  • Total Income:₹24,986.88 million for the nine months ended December 31, 2025.
  • Profit for the period:₹2,726.68 million for the nine months ended December 31, 2025.
  • Earnings per share (Basic):₹41.53 for the nine months.

Update on IPO Proceeds

The company provided an update on the utilization of net IPO proceeds, with ₹6,257.44 million being the total amount to be utilized as per the prospectus. Key allocations included the repayment of borrowings, expansion of manufacturing facilities, and investments in subsidiaries.

Details on QIP Proceeds

The company has also provided updates on the utilization of Qualified Institutional Placement (QIP) proceeds. They have raised capital through multiple QIPs to further support expansion and inorganic growth opportunities.

Source: BSE

Previous Article

Healthcare Global Board Approves Financial Results and New ESOP Scheme

Next Article

Senco Gold Board to Consider Financial Results and Interim Dividend